homocysteine has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoki, K; Esaki, M; Hirose, H; Ikeda, M; Kosuge, T; Morizane, C; Ohnami, S; Okusaka, T; Saito, D; Saito, I; Sakamoto, H; Sakamoto, Y; Sato, Y; Shimada, K; Sugimura, H; Ueno, H; Yoshida, T; Yoshimura, K | 1 |
1 other study(ies) available for homocysteine and Carcinoma, Ductal, Pancreatic
Article | Year |
---|---|
His595Tyr polymorphism in the methionine synthase reductase (MTRR) gene is associated with pancreatic cancer risk.
Topics: Adult; Aged; Carcinoma, Pancreatic Ductal; Case-Control Studies; Cell Line; Culture Media; DNA Methylation; Female; Ferredoxin-NADP Reductase; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Homocysteine; Humans; Japan; Long Interspersed Nucleotide Elements; Male; Middle Aged; Mutation, Missense; Odds Ratio; Pancreatic Neoplasms; Polymorphism, Single Nucleotide; Risk Assessment; Risk Factors; Transfection | 2008 |